Mindray Medical
International Limited (NYSE: MR), a leading developer, manufacturer and
marketer of medical devices worldwide, today announced shareholder resolutions
adopted at its annual general meeting of shareholders held in Hong Kong on
December 15, 2009.
At the meeting, Mindray Medical International's shareholders approved the
re-election of directors Mr. Xu Hang, Mr. Chen Qingtai, and Mr. Ronald Ede,
each to serve a three-year term.
Mindray shareholders also ratified the appointment of
PricewaterhouseCoopers as the company's independent registered public
accounting firm for the 2008 and 2009 fiscal years.
Additionally, Mindray shareholders approved an amendment to increase by
6,000,000 the number of shares that may be delivered pursuant to awards
granted under the Company's 2006 Employee Share Incentive Plan; the new share
limit shall be 21,000,000.
SOURCE Mindray Medical International Limited
Mindray net revenues increase 8.9% to $334.5 million in Q2 2014